Stage IIIC Cutaneous Melanoma AJCC v7 Recruiting Phase 0 Trials for Imiquimod (DB00724)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0091049 (Stage IIIC Cutaneous Melanoma AJCC v7) | Recruiting | 0 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03276832 | Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma | Treatment |